Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ: PCSA · Real-Time Price · USD

2.960

-0.110 (-3.58%)

At close: May 15, 2026, 4:00 PM EDT

2.800

-0.160 (-5.41%)

After-hours: May 15, 2026, 6:32 PM EDT

Processa Pharmaceuticals Employees

Processa Pharmaceuticals had 12 employees as of December 31, 2025. The number of employees increased by 2 or 20.00% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

20.00%

Revenue / Employee

n/a

Profits / Employee

-$1,175,551

Market Cap

7.87M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	12	2	20.00%
Dec 31, 2024	10	-3	-23.08%
Dec 31, 2023	13	-2	-13.33%
Dec 31, 2022	15	0	-
Dec 31, 2021	15	1	7.14%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Evogene	52
BioAtla	41
Bolt Biotherapeutics	23
Genprex	13
NuCana	12
Can-Fite BioPharma	5
Creative Medical Technology Holdings	4
Xenetic Biosciences	2